Blog
RSS FeedPosted by Michael Wonder on 18 Dec 2016
Tailored scientific advice to support step-by-step development of new biosimilars
16 December 2016 - Pilot project to commence in February 2017. ...
Posted by Michael Wonder on 13 Dec 2016
EMA hosts workshop on adaptive pathways
13 December 2016 - Broad range of stakeholder questions addressed. ...
Posted by Michael Wonder on 06 Dec 2016
Twelfth joint EMA/EUnetHTA dialogue meeting
5 December 2016 - The 12th joint meeting between the EMA and the European network for Health Technology Assessment (EUnetHTA) will ...
Posted by Michael Wonder on 29 Nov 2016
Development challenges for medicines for central nervous system disorders
29 November 2016 - EMA conducts analysis of applications submitted between 1995 and 2014. ...
Posted by Michael Wonder on 19 Nov 2016
Workshop: towards new treatments for tuberculosis
18 November 2016 - The event will be broadcast on 25 November 2016. ...
Posted by Michael Wonder on 16 Nov 2016
How can clinical research networks support developers of medicines for children?
16 November 2016 - Event to be broadcast live on 1 December 2016. ...
Posted by Michael Wonder on 15 Nov 2016
The European Commission launches a public consultation on the Paediatric Regulation
15 November 2016 - This marks ten years since the legislation entered into force. ...
Posted by Michael Wonder on 15 Nov 2016
Revising the guideline on first-in-human clinical trials
15 November 2016 - Changes are open for comments until end of February 2017. ...
Posted by Michael Wonder on 14 Nov 2016
Modelling and simulation in the development of medicines
14 November 2016 - Watch live broadcast of expert discussion at EMA. ...
Posted by Michael Wonder on 14 Nov 2016
How to facilitate development of cancer treatment based on genetically modified T-cells
8 November 2016 - Watch live broadcast of expert discussion at EMA. ...
Posted by Michael Wonder on 13 Nov 2016
How big data can be used for the development and regulation of medicines
8 November 2016 - EMA workshop broadcast live on 14-15 November. ...
Posted by Michael Wonder on 20 Oct 2016
Opening up clinical data on new medicines
20 October 2016 - EMA provides public access to clinical reports. ...
Posted by Michael Wonder on 19 Oct 2016
EMA updates list of PRIME priority medicines
19 October 2016 - The EMA has added three new technologies to the list following last week's CHMP meeting. ...
Posted by Michael Wonder on 19 Oct 2016
Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards
19 October 2016 - Measures of health-related quality of life and other patient-reported outcomes generate important data in cancer randomised trials ...
Posted by Michael Wonder on 26 Sep 2016
EU-US collaboration to boost medicine development for rare diseases
26 September 2016 - The EMA and the U.S. FDA have set up a new ‘cluster’ on rare diseases to share ...